PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
21493098-10	2011	CONCLUSIONS: This study provides evidence for successful conversion from tacrolimus BID to QD on a 1:1 (mg/mg) total daily dose basis.	Tacrolimus	73-83	BH3 interacting domain death agonist	Homo sapiens	84-87	
21493098-13	2011	Adverse events were reported by approximately one-tenth of patients receiving tacrolimus BID and a quarter of those who received QD.	Tacrolimus	78-88	BH3 interacting domain death agonist	Homo sapiens	89-92